Donna L. Tempel
Vorstandsvorsitzender bei Drais Pharmaceuticals Inc.
Profil
Donna L.
Tempel was the founder of AkaRx, Inc. (founded in 2005) where she held the title of Chief Operating Officer & Head-Investor Relations.
She is also the founder of Drais Pharmaceuticals Inc. (founded in 2007) where she holds the title of President & Chief Executive Officer.
Currently, Dr. Tempel is the President & Chief Executive Officer at Seldar Pharma, Inc. In the past, she has worked as Vice Chairman at BioNJ, Inc., Principal at Bristol Myers Squibb Co., Principal at Johnson & Johnson, and Chief Operating Officer at Yamanouchi Pharma America, Inc. Dr. Tempel completed her undergraduate degree at Hunter College, obtained an MBA from Fairleigh Dickinson University, and holds a doctorate from John Jay College of Criminal Justice.
Aktive Positionen von Donna L. Tempel
| Unternehmen | Position | Beginn |
|---|---|---|
Drais Pharmaceuticals Inc.
 Drais Pharmaceuticals Inc. Pharmaceuticals: MajorHealth Technology Drais Pharmaceuticals, Inc. manufactures pharmaceutical and provides therapeutic treatments. The company was founded by Donna L. Tempel and Robert E. Desjardins in 2007 and is headquartered in Bridgewater, NJ. | Vorstandsvorsitzender | 01.01.2008 |
Seldar Pharma, Inc.
 Seldar Pharma, Inc. Pharmaceuticals: MajorHealth Technology Seldar Pharma, Inc. develops and commercializes astellas for irritable bowel syndrome with diarrhea. The company is headquartered in Bridgewater, NJ. | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Donna L. Tempel
| Unternehmen | Position | Ende |
|---|---|---|
BioNJ, Inc.
 BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services BioNJ, Inc. is based in Trenton, NJ. BioNJ, Inc. is a life sciences trade association with nearly 400 member companies. The company supports the discovery, development, and commercialization of therapies and cures that save and improve lives. BioNJ drives capital formation, fosters entrepreneurship, advocates for medical innovation, provides access to talent and education, and offers critical commercial resources. The company also serves as a clearinghouse for funding information and opportunities. The company was founded in 1994 by James J. Marino, Jayne C. Gershkowitz, Abraham Abuchowski. The CEO is Debbie Hart. | Direktor/Vorstandsmitglied | - |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
| JOHNSON & JOHNSON | Corporate Officer/Principal | - |
| Yamanouchi Pharma America, Inc. | Geschäftsführer | - |
AkaRx, Inc.
 AkaRx, Inc. Pharmaceuticals: MajorHealth Technology AkaRx, Inc. engages in the develop and manufacture of biopharmaceutical products for applications in hematology and therapeutic treatments for clinical-stage cancer. It offers thrombocytopenia treatment avatrombopag. The company was founded by Robert E. Desjardins and Donna Tempel in 2005 and is headquartered in NJ. | Gründer | - |
Ausbildung von Donna L. Tempel
| Hunter College | Undergraduate Degree |
| John Jay College of Criminal Justice | Doctorate Degree |
| Fairleigh Dickinson University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| JOHNSON & JOHNSON | Health Technology |
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| Private Unternehmen | 5 |
|---|---|
AkaRx, Inc.
AkaRx, Inc. Pharmaceuticals: MajorHealth Technology AkaRx, Inc. engages in the develop and manufacture of biopharmaceutical products for applications in hematology and therapeutic treatments for clinical-stage cancer. It offers thrombocytopenia treatment avatrombopag. The company was founded by Robert E. Desjardins and Donna Tempel in 2005 and is headquartered in NJ. | Health Technology |
Drais Pharmaceuticals Inc.
Drais Pharmaceuticals Inc. Pharmaceuticals: MajorHealth Technology Drais Pharmaceuticals, Inc. manufactures pharmaceutical and provides therapeutic treatments. The company was founded by Donna L. Tempel and Robert E. Desjardins in 2007 and is headquartered in Bridgewater, NJ. | Health Technology |
| Yamanouchi Pharma America, Inc. | |
BioNJ, Inc.
BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services BioNJ, Inc. is based in Trenton, NJ. BioNJ, Inc. is a life sciences trade association with nearly 400 member companies. The company supports the discovery, development, and commercialization of therapies and cures that save and improve lives. BioNJ drives capital formation, fosters entrepreneurship, advocates for medical innovation, provides access to talent and education, and offers critical commercial resources. The company also serves as a clearinghouse for funding information and opportunities. The company was founded in 1994 by James J. Marino, Jayne C. Gershkowitz, Abraham Abuchowski. The CEO is Debbie Hart. | Commercial Services |
Seldar Pharma, Inc.
Seldar Pharma, Inc. Pharmaceuticals: MajorHealth Technology Seldar Pharma, Inc. develops and commercializes astellas for irritable bowel syndrome with diarrhea. The company is headquartered in Bridgewater, NJ. | Health Technology |
